Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

GKOS

Glaukos (GKOS)

Glaukos Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:GKOS
DateTimeSourceHeadlineSymbolCompany
25/01/202510:33Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNYSE:GKOSGlaukos Corporation
23/01/202523:00Business WireGlaukos to Release Fourth Quarter and Full Year 2024 Financial Results after Market Close on February 20NYSE:GKOSGlaukos Corporation
15/01/202508:05Edgar (US Regulatory)Form 8-K - Current reportNYSE:GKOSGlaukos Corporation
15/01/202508:05Business WireGlaukos Announces Positive Clinical Updates for its iDose® Sustained-Release Procedural Pharmaceutical PlatformNYSE:GKOSGlaukos Corporation
03/01/202512:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:GKOSGlaukos Corporation
03/01/202512:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:GKOSGlaukos Corporation
03/01/202512:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:GKOSGlaukos Corporation
03/01/202512:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:GKOSGlaukos Corporation
24/12/202413:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:GKOSGlaukos Corporation
24/12/202411:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:GKOSGlaukos Corporation
23/12/202423:00Business WireGlaukos Submits New Drug Application to U.S. FDA for Epioxaâ„¢NYSE:GKOSGlaukos Corporation
21/12/202408:27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:GKOSGlaukos Corporation
21/12/202408:21Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:GKOSGlaukos Corporation
17/12/202423:00Business WireGlaukos Announces Participation in the J.P. Morgan Healthcare ConferenceNYSE:GKOSGlaukos Corporation
14/12/202411:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:GKOSGlaukos Corporation
12/12/202404:32Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:GKOSGlaukos Corporation
09/12/202422:30Edgar (US Regulatory)Form 8-K - Current reportNYSE:GKOSGlaukos Corporation
03/12/202422:02Edgar (US Regulatory)Form 8-K - Current reportNYSE:GKOSGlaukos Corporation
15/11/202423:00Edgar (US Regulatory)Form 8-K - Current reportNYSE:GKOSGlaukos Corporation
08/11/202423:00Business WireGlaukos Announces Participation in Upcoming Investor ConferencesNYSE:GKOSGlaukos Corporation
05/11/202408:10Edgar (US Regulatory)Form 8-K - Current reportNYSE:GKOSGlaukos Corporation
05/11/202408:05Business WireGlaukos Announces Third Quarter 2024 Financial ResultsNYSE:GKOSGlaukos Corporation
02/11/202408:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:GKOSGlaukos Corporation
31/10/202407:18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:GKOSGlaukos Corporation
17/10/202409:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:GKOSGlaukos Corporation
17/10/202409:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:GKOSGlaukos Corporation
17/10/202407:05Business WireGlaukos Announces Positive Topline Outcomes in Phase 3 Confirmatory Trial for Epioxaâ„¢, Achieving Primary Efficacy Endpoint and Demonstrating Favorable Tolerability and SafetyNYSE:GKOSGlaukos Corporation
14/10/202422:00Business WireGlaukos To Present Multiple Scientific Abstracts at the 2024 American Academy of Ophthalmology Annual MeetingNYSE:GKOSGlaukos Corporation
12/10/202408:27Edgar (US Regulatory)Form 8-K - Current reportNYSE:GKOSGlaukos Corporation
09/10/202422:00Business WireGlaukos to Release Third Quarter 2024 Financial Results after Market Close on November 4NYSE:GKOSGlaukos Corporation
 Showing the most relevant articles for your search:NYSE:GKOS